Tuberculosis infection in patients with dermatomyositis
Submitted: 8 August 2023
Accepted: 25 October 2024
Published: 7 March 2025
Accepted: 25 October 2024
Abstract Views: 28
PDF: 14
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- G. Cassone, M. Sebastiani, L. Cavagna, K. Triantafyllias, V. Codullo, C. Salvarani, A. Manfredi, Nailfold videocapillaroscopy in antisynthetase syndrome , Reumatismo: Vol. 70 No. 4 (2018)
- A. Ghirardello, S. Zampieri, L. Iaccarino, E. Tarricone, M. Tonello, R. Bendo, R. Rondinone, F. Cozzi, A. Doria, Myositis specific and myositis associated autoantibodies in idiopathic inflammatory myopathies: a serologic study of 46 patients , Reumatismo: Vol. 57 No. 1 (2005)
- F. Trotta, G. Valentini, Safety of anti-TNFa biological drugs , Reumatismo: Vol. 57 No. s4 (2005)
- Irene Pontikaki, Valeria Gerloni, Maurizio Gattinara, Alfredomaria Lurati, Alessandra Salmaso, Gabriele De Marco, Barbara Teruzzi, Elisabetta Valcamonica, Flavio Fantini, Side effects of anti-TNFa therapy in juvenile idiopathic arthritis , Reumatismo: Vol. 58 No. 1 (2006)
- C. Botsios, P. Sfriso, A. Furlan, P. Ostuni, M. Biscaro, U. Fiocco, S. Todesco, L. Punzi, Anakinra, a recombinant human IL-1 receptor antagonist, in clinical practice. Outcome in 60 patients with severe rheumatoid arthritis , Reumatismo: Vol. 59 No. 1 (2007)
- P. Sfriso, F. Salaffi, C.M. Montecucco, S. Bombardieri, S. Todesco, MonitorNet: studio italiano osservazionale multicentrico per la valutazione del profilo rischio-beneficio dei farmaci biologici nella pratica clinica reumatologica , Reumatismo: Vol. 61 No. 2 (2009)
- R. Gutiérrez-Ramos, V. González-Díaz, M.G. Pacheco-Tovar, A. López-Luna, E. Avalos-Díaz, R. Herrera-Esparza, A dermatomyositis and scleroderma overlap syndrome with a remarkable high titer of anti-exosome antibodies , Reumatismo: Vol. 60 No. 4 (2008)
- V. Gerloni, I. Pontikaki, M Gattinara, F. Fantini, Biological therapy with TNF-inhibitors in pediatric rheumatology. Review of the litterature and personal experience , Reumatismo: Vol. 59 No. 3 (2007)
You may also start an advanced similarity search for this article.